On ECHEMI
Home > Drugs > Carmofur Registered Holders
Carmofur structure

Carmofur structure

Carmofur

Carmofur is a derivative of fluorouracil, an antimetabolite used as an antineoplastic agent. Target: Nucleoside antimetabolite/analogCarmofur, which is used in the clinic to treat colorectal cancers, is a potent AC inhibitor and that this property is essential to its anti-proliferative effects. Carmofur inhibited AC activity with a median effective concentration (IC50) of 29 ± 5 nM (mean ± standard error of the mean, s.e.m.; n = 4), whereas 5-FU had no such effect (IC50>1 mM). systemic a

Find 2 Related Holders

Shandong Anxin Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2019-09-02
  • Country:

    China China
  • Address:

    No. 10678, Wenliang Road, Dongjia Street, Licheng District, Jinan City
  • Tax NO.:

    91370100MA3QGRX746
  • Registered Funds:

    600 million yuan
  • Website:

  • Email:

Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2001-02-26
  • Country:

    China China
  • Address:

    No. 25, Juxian Road, Gedian Economic and Technological Development Zone, Ezhou, Hubei Province
  • Tax NO.:

    91420700726118497D
  • Registered Funds:

    128.255 million yuan
  • Website:

  • Email:

Recommended Suppliers of Carmofur
View 32 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.